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Abstract
Greater phosphorus intake has been associated with lower levels of blood pressure in cross-sectional
studies. This association, however, has not been assessed prospectively. We studied 13444
participants from the Atherosclerosis Risk in Communities cohort and the Multi-Ethnic Study of
Atherosclerosis, with diet assessed at baseline using validated food frequency questionnaires. Blood
pressure and use of antihypertensive medication were determined at baseline and during follow-up
visits. Compared to individuals in the lowest quintile of phosphorus intake at baseline, those in the
highest quintile had lower baseline systolic and diastolic blood pressure after adjustment for dietary
and non-dietary confounders (−2.0 mmHg, 95% confidence interval −3.6, −0.5; p for trend=0.01;
and −0.6, 95% confidence interval −1.6, +0.3, p for trend=0.20, respectively). During an average 6.2
years of follow-up, 3345 cases of hypertension were identified. Phosphorus intake was associated
with the risk of hypertension (hazard ratio 0.80, 95% confidence interval 0.80-1.00, comparing
extreme quintiles; p for trend=0.02) after adjustment for non-dietary factors, but not after additional
adjustment for dietary variables (hazard ratio 1.01, 95% confidence interval 0.82-1.23, p for
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trend=0.88). Phosphorus from dairy products but not from other sources was associated with lower
baseline blood pressure and reduced risk of incident hypertension. Hazard ratios (95% confidence
interval) comparing extreme quintiles were 0.86 (0.76-0.97), p for trend=0.01, for phosphorus from
dairy foods and 1.04 (0.93-1.17), p for trend=0.48, for phosphorus from other foods. These findings
could indicate an effect of phosphorus in conjunction with other dairy constituents or of dairy itself
without involvement of phosphorus.
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INTRODUCTION
Substantial evidence demonstrates that dietary factors affect the risk of hypertension.1 A diet
rich in potassium, fruits, vegetables, and low-fat dairy products, and low in sodium and alcohol
intake has been consistently associated with reduced levels of blood pressure (BP).2, 3 The
effect of other nutrients, such as calcium, magnesium, fiber, protein, or phosphorus is less clear.
1
A recent analysis from the International Study of Macro- and Micro-Nutrients and Blood
Pressure (INTERMAP), an international cross-sectional study including 4680 individuals,
showed that a higher phosphorus intake, independently of other nutrients, was associated with
lower BP levels.4 Similarly, in the US National Health and Nutrition Examination Survey
(NHANES), phosphorus intake presented a weak inverse association with systolic and diastolic
BP.5 No prospective studies, however, have examined whether phosphorus intake might be
associated with a reduced risk of hypertension.
Determining the relationship between dietary phosphorus and the risk of incident hypertension
is particularly relevant, since phosphorus in the diet could affect levels of serum phosphorus,
as shown in some studies 6-8 (though not in others).9-11 Elevated serum phosphorus levels, in
turn, could increase the risk of cardiovascular events.12-14 Additionally, the intake of
phosphorus in the US population has increased considerably in the last decades, particularly
due to the important amount of phosphorus food additives in processed foods.15 Therefore,
assessing the overall cardiovascular effect of dietary phosphorus, whether beneficial or
deleterious, is a crucial public health need.
We examined the association of phosphorus intake with BP levels and risk of hypertension in
two population-based studies in the US: the Atherosclerosis Risk in Communities (ARIC)
Study and the Multi-Ethnic Study of Atherosclerosis (MESA). Additionally, we assessed
whether phosphorous from different dietary sources was equally related to hypertension.
METHODS
Study population
The ARIC Study is a population-based cohort study aimed to identify risk factors for
cardiovascular diseases in 4 US communities.16 Between 1987 and 1989, 15,792 men and
women aged 45-64 were recruited from Washington County, MD, Forsyth County, NC,
Jackson, MS, and suburbs of Minneapolis, MN. Participants underwent a baseline clinical
examination. Follow-up examinations of the cohort occurred three times, at intervals of roughly
three years. The sample included 27% African-Americans and 73% whites.
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From July 2000 to September 2002, MESA recruited 6814 men and women, aged 45-84 and
free of cardiovascular disease, from six different populations in the US: Baltimore, MD,
Chicago, IL, St. Paul, MN, Forsyth County, NC, New York, NY, and Los Angeles, CA. 17
MESA conducted three follow-up examinations between 2002 and 2007. The race/ethnicity
distribution was 41% white, 26% African-American, 21% Hispanic, and 12% Chinese-
American.
Study participants who at baseline had diabetes or cardiovascular disease, or were taking
antihypertensive medication were excluded from all analyses. We also excluded individuals
with missing values in any of the covariates or who provided insufficient or implausible dietary
information (missing diet data or extreme energy intake, as described elsewhere).18, 19 In the
longitudinal analysis, we additionally excluded those who did not attend any follow-up visit
or had systolic BP≥140 or diastolic BP≥90 at the baseline exam. Finally, in ARIC we excluded
a small number of individuals who were not white in the Minnesota and Washington County
site, or not white or black in the Forsyth County site; these exclusions were done to allow
multivariate adjustment for race and study site. Response rates among survivors for the
successive examinations were 93%, 86%, and 80% in ARIC, and 91%, 87%, and 85% in
MESA.
Institutional Review Boards from all participating institutions approved the study; study
participants provided written informed consent.
Diet assessment
In ARIC, diet was assessed at baseline using a 66-item food frequency questionnaire (FFQ)
based on the 61-item FFQ developed by Willett et al.20 Participants reported usual frequency
of food consumption in 9 categories, from never or less than once a month to 6 or more times
per day. Average daily intake of nutrients was calculated by multiplying the frequency of
consumption of each food item by its nutrient content and adding up the nutrient intake for all
items.
Dietary data in MESA was assessed at baseline using a 120-item FFQ, developed according
to the validated Block format.21 The MESA FFQ was adapted from the Insulin Resistance
Atherosclerosis Study FFQ, modified to include unique Chinese foods and culinary practices.
Information from the food-specific portion of the questionnaire was converted to approximate
daily intake amounts of the micronutrients in the food using the Nutrition Data Systems for
Research database (NDS-R, Nutrition Coordinating Center University of Minnesota;
Minneapolis, MN).22
Nutrient intake was adjusted for total energy intake using the residual method, and categorized
in sex-specific quintiles.23
Blood pressure measurement
At the ARIC baseline and follow-up visits, BP was measured by certified technicians with a
random-zero sphygmomanometer. The second and third of 3 measurements were averaged to
estimate systolic and diastolic BP. In MESA, BP was also measured at baseline and at each
follow-up examination. Three seated BP measurements were taken 5 minutes apart by using
an automated device (Dinamap Pro 100). The mean of the last 2 measurements was considered
for analysis. Use of antihypertensive medication was assessed by questionnaire at all visits in
both ARIC and MESA. A study participant was labeled as hypertensive (prevalent or incident)
if she or he had systolic BP ≥140 mmHg, or diastolic BP ≥90 mmHg, or was currently using
antihypertensive medication.
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Assessment of other covariates
Measurement of other covariates is detailed in an online supplement. Please see
http://hyper.ahajournals.org
Statistical analysis
Analyses were conducted separately in each cohort. Heterogeneity between cohorts was
assessed with the Cochran’s Q statistic.24 If no evidence of heterogeneity was apparent, cohort-
specific results were pooled, weighted by the inverse of their variance.
To study the cross-sectional association between baseline phosphorus intake and BP levels,
we fitted separate multiple linear regression models for systolic and diastolic BP. An initial
model included quintiles of phosphorus intake, as a categorical variable, age, sex, and race as
independent variables. In a subsequent model, we added the following potential confounders:
study site, body mass index (considered as a continuous variable), waist circumference
(continuous), education (ordinal), income (ordinal), physical activity (continuous), eGFR
(continuous), cigarette smoking (current, former, never), alcohol intake (continuous), and
energy intake (continuous). Finally, a third model additionally adjusted for quintiles of other
nutrients and foods: calcium, potassium, magnesium, sodium, vitamin D (only in ARIC), daily
servings of fruits and vegetables, and daily serving of whole grains.
In the longitudinal analysis, we estimated hazard ratios (HR) of incident hypertension and their
95% confidence intervals (CI) by quintiles of phosphorus intake using Cox proportional
hazards regression, with the lowest quintile as reference category. The main independent
variable was time from baseline exam to the exam date in which hypertension was first
diagnosed. Study participants were censored if they did not have hypertension by the time of
their last study visit. As with the cross-sectional analysis, we ran different models including
increasing number of potential confounders. Trends across quintiles of phosphorus intake were
estimated assigning the quintile-specific median intake of phosphorus to all individuals in that
quintile, and including the resulting value as a continuous variable in regression models.
If a nutrient is related to an outcome, the association should be seen independently from the
food which it is derived. Because dairy products are the main source of dietary phosphorus and
given the known inverse association between dairy product intake and risk of hypertension,
we conducted separate analyses using dietary phosphorus from dairy products, and dietary
phosphorus from other sources as main exposure variables. Phosphorus intake from different
sources was calculated with a cohort-specific multivariable regression model, with daily
phosphorus intake as the dependent variable, and daily servings of each food item in the FFQ
as independent variables. The coefficients obtained from this model were multiplied by the
average number of servings per day for each food item, providing the average daily phosphorus
intake from the corresponding food.
In an online supplement, we have included additional details on sensitivity and stratified
analyses (please see http://hyper.ahajournals.org).
All statistical analyses were conducted using SAS v 9.2 (SAS Inc, Cary, NC).
RESULTS
From the initial 15,792 ARIC and 6814 MESA participants, 9785 from ARIC and 3659 from
MESA met inclusion criteria for the cross-sectional analysis. Of these, 8208 ARIC and 2901
MESA participants were also included in the longitudinal analysis. Figure 1 presents a flow
diagram of participants in ARIC and MESA, and the different reasons for exclusion. In both
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studies, the main reason for exclusion was the use of antihypertensive medications or high
blood pressure levels at baseline.
Tables 1 and 2 report selected characteristics of ARIC and MESA participants by sex-specific
quintiles of phosphorus intake. Average phosphorus intake was similar in both cohorts (1084
mg/day in ARIC, 1103 mg/day in MESA). Individuals with higher phosphorus intake were
older, more likely to be educated, and had an overall healthier lifestyle profile than those with
low phosphorus intake. Thus, they were more likely to be non-smokers and physically active,
had lower alcohol intake, and higher intake of calcium, potassium, magnesium, sodium, fruits
and vegetables, and whole grains. Whites had higher phosphorus intake and, in MESA,
African-Americans had lower phosphorus intake than Chinese-Americans and Hispanics.
Correlations between phosphorus and other dietary minerals were relatively strong: 0.80 and
0.92 with calcium, 0.66 and 0.68 with potassium, 0.66 and 0.69 with magnesium, in ARIC and
MESA respectively.
In the baseline cross-sectional analysis, higher phosphorus intake was associated with lower
levels of systolic and diastolic BP in both cohorts, even after adjustment for potential
confounders (table 3; models 1 and 2). In models adjusted for sociodemographic variables and
the main risk factors for high BP, systolic BP in ARIC participants in the highest quintile of
phosphorus intake was 2.3 mmHg lower (95% CI, 1.3, 2.3) than in those in the lowest quintile.
Among MESA participants, results were similar (difference in systolic BP between extreme
quintiles: −2.3 mmHg, 95% CI, −4.2, −0.5). Smaller differences were observed for diastolic
BP (ARIC: −0.9 mmHg, 95% CI −1.5, −0.3; MESA: −1.4 mmHg, 95% CI −2.3, −0.4,
comparing extreme quintiles). Cochran’s Q statistic did not provide evidence of heterogeneity.
Subsequent adjustment for other dietary factors attenuated the associations between
phosphorus intake and BP. Still, the pooled analysis showed an association of phosphorus
intake with systolic BP (table 3, model 3: −2.0 mmHg, 95% CI −3.6, −0.5, comparing extreme
quintiles).
During an average follow-up of 6.2 years (7.1 in ARIC, 3.8 in MESA), 3345 incident cases of
hypertension (2400 in ARIC, 945 in MESA) were identified. Individuals in the top quintile of
phosphorus intake had approximately a 10% lower risk of hypertension than those in the lowest,
after adjustment for potential confounders (table 4, models 1 and 2). HRs (95% CI) of
hypertension comparing extreme quintiles were 0.89 (0.78, 1.03) in ARIC, 0.90 (0.73, 1.10)
in MESA, and 0.89 (0.80, 1.00) in the pooled analysis. The association disappeared after
adjustment for other dietary factors (table 4, model 3). Results were virtually identical when
we used Poisson regression instead of Cox models (data not shown). Restricting the definition
of incident hypertension to systolic BP ≥140 or diastolic ≥90, without considering use of
antihypertensive medications, or including only participants with systolic and diastolic BP
<130/80 at baseline did not appreciably change the results (data not shown). Similarly, analyses
restricted to never smokers, or adjusting additionally for pack-years of smoking, season of
baseline BP measurement, or weight provided similar results.
In analyses stratified by sex, greater phosphorus intake was similarly associated with lower
risk of hypertension in men and women. The HR (95% CI) of hypertension comparing extreme
quintiles of phosphorus intake was 0.86 (0.72, 1.03) in men and 0.93 (0.80, 1.09) in women
(tables S1 and S2; please see http://hyper.ahajournals.org). Results stratified by race/ethnicity
did not provide strong evidence of interaction, though the limited sample size among non-
whites precluded drawing any meaningful conclusion (tables S3 and S4; please see
http://hyper.ahajournals.org). Finally, no evidence of interaction by renal function was
apparent (data not shown).
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The main source of dietary phosphorus in both cohorts was dairy products (31% in ARIC, 29%
in MESA), followed by fish (7%), red meat (7%), poultry (5%) and whole-grain bread (5%)
in ARIC, and by white bread (6%), red meat (5%), whole grain bread (5%) and legumes (5%)
in MESA. We estimated separately the association of phosphorus intake from dairy and non-
dairy sources with cross-sectional BP levels and the risk of incident hypertension. Results are
shown in figures 2 and 3. Overall, only higher phosphorus intake from dairy products, but not
from other dietary sources, was consistently associated with lower levels of systolic BP and
lower risk of hypertension.
We conducted an additional analysis correcting diet measurement error using regression
calibration.25 A 500 mg/day higher phosphorus intake was associated with 1.1 mmHg lower
systolic BP (95% CI 0.5, 1.8) in the uncorrected analysis and 2.1 (95% CI 1.1, 3.0) in the
corrected analysis. HR (95% CI) of hypertension associated with the same difference in
phosphorus intake was 0.93 (0.87, 1.00) in the uncorrected analysis, and 0.88 (0.79, 0.99) in
the corrected (detailed results are presented in tables S5 and S6, please see
http://hyper.ahajournals.org).
DISCUSSION
In this analysis of two large population-based cohorts, we have found that phosphorus intake
was inversely associated with systolic blood pressure levels, even after adjustment for
confounders and highly correlated nutrients. Additionally, we observed a lower risk of
hypertension among individuals with a higher phosphorus intake, but this association was
considerably attenuated after adjusting for other dietary factors. More importantly, we found
that these associations were only present for dietary phosphorus from dairy products but not
for phosphorus from other dietary sources. As a whole, our results suggest that dairy foods,
but not phosphorus per se, might have a beneficial effect on BP.
A few previous epidemiologic studies have assessed the association of phosphorus intake with
BP levels. In the INTERMAP study, which included 4680 individuals from Japan, China, US,
and the United Kingdom whose diet was assessed with multiple 24-hour recalls, increments
of 2 standard deviations in phosphorus intake were associated with 2.2 mmHg and 1.7 mmHg
lower systolic and diastolic BP in multivariable analysis.4 Similar results were found among
615 men of Japanese ancestry living in Hawaii, with those in the upper quintile of phosphorus
intake, measured with one 24-hour recall, having 3.2mmHg lower systolic BP and 2.0 mmHg
lower diastolic BP than those in the lowest quintile, after adjusting for age and body mass
index.26 Finally, a cross-sectional analysis of 4519 NHANES 1999-2004 participants found
that higher phosphorus intake, also assessed with one 24-hour recall, was weakly associated
with lower levels of BP (−0.04 and −0.03 per each 100 mg phosphorus/day),5 though results
in the opposite direction were found in NHANES I (1971-1975).27 Overall, existing data,
including our results, suggests that higher phosphorus intake is associated with lower BP in
cross-sectional analysis. Previous studies, however, did not explore whether this association
varied according to dietary source of phosphorus.
We have found that only phosphorus from dairy products was associated with lower BP and
decreased risk of hypertension in ARIC and MESA. A growing body of evidence suggests that
higher consumption of dairy products is associated with lower risk of hypertension. Low-fat
dairy products were a substantive part of the combination diet in the Dietary Approaches to
Stop Hypertension (DASH) trial (the so-called DASH diet). The DASH diet was more effective
in reducing BP than a diet rich in fruits and vegetables or a control diet.2 A number of
prospective cohort studies have found lower risk of hypertension in individuals with higher
dairy product intake (particularly low-fat dairy),28-33 including a recent analysis from the ARIC
cohort.34 Parallel to our results, calcium from dairy products but not from other sources was
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associated with lower risk of hypertension in another prospective study.30 Our results highlight,
once more, the importance of focusing on foods, in addition to nutrients, in nutritional
epidemiology;35 and offer additional evidence of the potential beneficial effect of dairy foods
on BP.
No convincing biological mechanism has been provided to explain how dietary phosphorus
could reduce BP. Though dietary phosphorus might increase serum phosphorus6-8 and this, in
turn, could be associated with lower BP,36 other studies have shown that dietary phosphorus
has a limited impact on serum phosphorus levels.9-11 In addition, dietary phosphorus might
have deleterious effects on BP. For example, dietary phosphorus loading has been associated
with impaired endothelium-dependent vasodilation.37 Also, higher phosphorus intake could
lead to lower levels of circulating 1-25-dihydroxy vitamin D,6 with lower serum levels of
vitamin D associated with higher BP levels.38 Alternatively, it might be other nutrients in dairy
foods, such as calcium, magnesium, potassium and lactopeptides, or their combination, that is
effective in reducing BP levels and the risk of hypertension.39 The present analysis supports
the latter explanation.
Our study has valuable strengths. We have analyzed data from two large cohorts, recruited in
different areas of the US, and including a multi-ethnic population. The prospective design
allowed us to estimate incidence rates of hypertension across categories of phosphorus intake.
Additionally, BP measurements were performed following cohort-specific standardized
protocols, reducing measurement error. We also accounted in the analysis for important
potential confounders, particularly multiple lifestyle-related behaviors. Finally, losses to
follow-up in both cohorts were limited, reducing the risk for selection bias.
As with other studies in nutritional epidemiology, one main limitation of the present analysis
is the potential for measurement error in the dietary assessment, particularly relevant for some
nutrients such as sodium. Food questionnaires used in both ARIC and MESA have been
previously validated,20, 21 but certain degree of non-differential misclassification is
unavoidable. We performed a regression-calibration analysis to partially remediate this
problem. Results did not appreciably change after measurement error correction, suggesting
that measurement error is unlikely to explain the observed associations.
Another major limitation is the high correlation of phosphorus with other nutrients potentially
associated with BP, such as calcium, magnesium or potassium. High correlations lead to
collinearity in multivariable models and, consequently, problems in the estimation of
associations. This explains, in part, the large confidence intervals in the association estimates
adjusted for other nutrients. High between-nutrient correlation, also, limits the ability of
observational studies to assess the health effects of individual nutrients.35 Finally, unmeasured
or residual confounding is an additional threat. Individuals with low or high phosphorus intake
were substantially different in their lifestyles and other potential risk factors for high BP. Even
though we have controlled for the major risk factors for hypertension, our results might
overestimate the true association if healthier individuals had higher phosphorus intake.
PERSPECTIVES
We have shown that, in two diverse populations, higher phosphorus intake is associated with
lower BP levels and a lower risk of hypertension, but these potential benefits seem to be
restricted to phosphorus obtained through the intake of dairy products. This finding could be
indicative of an effect of phosphorus in conjunction with other dairy constituents, or of dairy
itself, even without involvement of phosphorus. Additional research is required to determine
if other nutrients in dairy foods, or their combination, are responsible for this association.
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Participation flow diagram, ARIC and MESA.
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Cross-sectional difference in systolic BP (SBP) levels (and 95% confidence intervals) by
quintiles of phosphorus from dairy products (black squares) and phosphorus from non-dairy
foods (dark grey circles). Pooled results from ARIC and MESA. Linear regression model
adjusted for age, race, sex, body mass index, waist circumference, eGFR, education, income,
physical activity, cigarette smoking, study site, alcohol intake, and energy intake.
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Hazard ratios (HR) and 95% confidence intervals (CI) of hypertension by quintiles of
phosphorus from dairy products (black squares) and phosphorus from non-dairy foods (dark
grey circles). Pooled results from ARIC and MESA. Cox proportional hazard model adjusted
for age, race, sex, body mass index, waist circumference, eGFR, education, income, physical
activity, cigarette smoking, study site, alcohol intake, and energy intake.
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